Document is current

Article History

Received: 23 March 2026

Accepted: 25 June 2026

First Online: 15 July 2026

Declarations

Conflicts of Interest: Victoria Barbosa: Grants: Pfizer; consulting/advising fees: Lilly, Pfizer, Vichy, L’Oréal USA, and Veradermics; payment or honoraria: Vichy; CeraVe Leadership or fiduciary role in other board, society, committee or advocacy group: Skin of Color Society Immediate Past President (unpaid); Illinois Dermatological Society Vice President (unpaid). Tina Bhutani-Jacques: Dr. Bhutani has received research funding from Amgen, Castle, CorEvitas, Novartis, Pfizer, and Regeneron. She has served as an adviser for AbbVie, Arcutis, Aslan, Boehringer-Ingelheim, Bristol Myers Squibb, Dermavant, Galderma, Incyte, Janssen, Leo, Lilly, Pfizer, Novartis, Sanofi, Sun, Takeda, and UCB. She is a speaker for Abbvie, Amgen, Arcutis, BMS, Dermavant, Galderma, Janssen, Lilly, Leo, Ortho, Sanofi, and UCB. Leadership or fiduciary role in other board, society, committee or advocacy group: National Psoriasis Foundation Medical Advisory Board. Valerie D. Callender: Dr. Callender has received research funding from AbbVie/Allergan, Avava, Eli Lilly, Eirion Therapeutics, Estee Lauder, Incyte, L’Oréal, I Know Skincare, Janssen, Pfizer, Prollenium, Regeneron, Symatese, and Teoxane. She has served as a consultant and advisor for AbbVie/Allergan, Aerolase, Arcutis, Avava, Beiersdorf, Eli Lilly, Estee Lauder, Juenes Aesthetics, L’Oréal, Ortho Derm, and SkinCeuticals. She is a speaker for Arcutis, L’Oréal, and Pfizer. She receives loyalties from Elsevier and UpToDate. Elizabeth D. Bacci and Julia R. Correll: employees of PPD Evidera Patient-Centered Research, Thermo Fisher Scientific. Evangeline Pierce and Beth Mitchell: employment and shareholder, Eli Lilly and Company. Nicole Huang: nothing to disclose.

Ethical Approval: The study received approval from the Advarra Institutional Review Board. It was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki, Good Pharmacoepidemiology Practices, and applicable laws and regulations. Participants authorized the use and disclosure of their personal health information, covering the collection and release of data related to treatment and its outcomes throughout the study period. Confidentiality was maintained throughout the study, and all recruitment procedures complied with current Health Insurance Portability and Accountability Act regulations. Informed consent was obtained from all individual participants included in the study.